Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloride, Morphine
2. Contin, Ms
3. Duramorph
4. Morphia
5. Morphine
6. Morphine Chloride
7. Morphine Sulfate
8. Morphine Sulfate (2:1), Anhydrous
9. Morphine Sulfate (2:1), Pentahydrate
10. Ms Contin
11. Oramorph Sr
12. Sdz 202 250
13. Sdz 202-250
14. Sdz 202250
15. Sdz202 250
16. Sdz202-250
17. Sdz202250
18. Sulfate, Morphine
1. Morphine Sulfate
2. Schembl29317
3. Morphinesulfatenarcoticanalgesic
Molecular Weight | 383.4 g/mol |
---|---|
Molecular Formula | C17H21NO7S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 383.10387318 g/mol |
Monoisotopic Mass | 383.10387318 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 576 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
3 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
4 of 6 | |
---|---|
Drug Name | Astramorph pf |
PubMed Health | Morphine (Injection) |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
5 of 6 | |
---|---|
Drug Name | Duramorph pf |
Active Ingredient | Morphine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml; 0.5mg/ml |
Market Status | Prescription |
Company | Hikma Maple |
6 of 6 | |
---|---|
Drug Name | Morphine sulfate |
PubMed Health | Morphine Sulfate Liposome (Injection) |
Drug Classes | Analgesic, Anesthetic Adjunct, Central Nervous System Agent |
Drug Label | DESCRIPTIONChemically, morphine sulfate is 7, 8-didehydro-4, 5-epoxy-17-methylmorphinan-3, 6-diol sulfate (2:1) (salt) pentahydrate... |
Active Ingredient | Morphine sulfate |
Dosage Form | Tablet, extended release; Tablet; Injectable; Capsule, extended release; Solution |
Route | Intramuscular, intravenous; oral; Injection; Oral |
Strength | 2mg/ml; 200mg; 10mg/5ml; 1mg/ml; 8mg/ml (8mg/ml); 30mg; 10mg/ml (10mg/ml); 100mg/5ml; 90mg; 15mg; 120mg; 4mg/ml (4mg/ml); 10mg/ml; 0.5mg/ml; 2mg/ml (2mg/ml); 75mg; 4mg/ml; 5mg/ml; 100mg; 5mg/ml (5mg/ml); 8mg/ml; 50mg; 60mg; 10mg; 15mg/ml; 20mg/5ml; 80mg; |
Market Status | Prescription |
Company | Clonmel Hlthcare; Vintage Pharms; Mylan Pharms; Upsher Smith; Hospira; Mallinckrodt; Rhodes Pharms; Meridian Medcl; Par Pharm; Roxane; Lannett Holdings; Nesher Pharms; Vistapharm; Actavis Elizabeth; Paddock; Caraco; Ranbaxy Labs; Bd Rx |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
Narcotics
Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-29
Pay. Date : 2014-08-18
DMF Number : 21588
Submission : 2008-04-30
Status : Active
Type : II
Certificate Number : CEP 2001-239 - Rev 07
Issue Date : 2024-06-20
Type : Chemical
Substance Number : 1244
Status : Valid
NDC Package Code : 49812-0149
Start Marketing Date : 2005-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-07-13
Registration Number : 20190812-209-J-406(2)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom
Available Reg Filing : ROW |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Certificate Number : CEP 2000-126 - Rev 07
Issue Date : 2024-04-26
Type : Chemical
Substance Number : 1244
Status : Valid
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-05
Pay. Date : 2012-11-23
DMF Number : 6967
Submission : 1987-05-08
Status : Active
Type : II
NDC Package Code : 67509-004
Start Marketing Date : 2015-11-25
End Marketing Date : 2026-05-04
Dosage Form (Strength) : POWDER (40kg/40kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73548-8031
Start Marketing Date : 2023-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.1kg/.1kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2020-05-20
Registration Number : 20190812-209-J-406(1)
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, Scotland, United Kingdom
Available Reg Filing : ROW |
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2019-08-12
Registration Number : 20190812-209-J-406
Manufacturer Name : Macfarlan Smith Limited
Manufacturer Address : 10 Wheatfield Road, Edinburgh, EH11 2QA, Scotland, United Kingdom
Available Reg Filing : ROW |
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-19
Pay. Date : 2015-12-10
DMF Number : 29317
Submission : 2015-11-25
Status : Active
Type : II
NDC Package Code : 51634-0969
Start Marketing Date : 2000-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : Veranova is a global leader in the development and manufacturing of specialist and complex APIs for pharma and biotech customers. We have over 50 years of experience navigating the...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
About the Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs with approximately ...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...
About the Company : Alcaliber is a benchmark in the World Drug Industry both in terms of quality and innovation, integrity and commitment to our customers. We are a leading company: in 2014 we were th...
About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...
About the Company : Hameln rds s.r.o. located in Slovakia, Europe, part of the European Union, is a well-known pharmaceutical company producing APIs and services for the healthcare industry, with focu...
About the Company : Established in 1995, Kimyagaran Emrooz Chemical Industries Co. is recognized as one of the major leading production enterprises in the ethoxylation and propoxylation industry for m...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1996-07-03
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 1996-07-03
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 30MG
Packaging :
Approval Date : 2001-03-09
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 60MG
Packaging :
Approval Date : 2001-03-09
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 80MG
Packaging :
Approval Date : 2006-10-27
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2007-02-27
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2007-04-20
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 70MG
Packaging :
Approval Date : 2012-07-09
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 130MG
Packaging :
Approval Date : 2012-07-09
Application Number : 20616
Regulatory Info : DISCN
Registration Country : USA
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Co-Processed Excipients
Excipient Details : Mannitol is a co-processed excipient with superior compactibility, lower disintegration time, and hygroscopicity.
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph :
Storage :
Code/Batch No : 7685
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph :
Storage :
Code/Batch No : 7685
CAS Number :
Quantity Per Vial :
Sale Unit :
Price :
Details :
Monograph :
Storage :
Code/Batch No : 1522
Morphine Monohydrate CII (50 mg) (AS)
CAS Number : 6009-81-0
Quantity Per Vial : 50
Sale Unit : mg
Price : $320.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1447002 / G1F125
CAS Number : 6211-15-0
Quantity Per Vial : 500
Sale Unit : mg
Price : $520.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1448005 / R118G0
Morphine Related Compound A CI (20 mg) (7,8-D...
CAS Number : 639-46-3
Quantity Per Vial : 20
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1448016 / R104N0
Morphine Related Compound B CII (20 mg) (2,2\...
CAS Number : 6472-73-7
Quantity Per Vial : 20
Sale Unit : mg
Price : $775.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1448027 / R104G1
ABOUT THIS PAGE
18
PharmaCompass offers a list of Morphine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Morphine Sulfate manufacturer or Morphine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Morphine Sulfate manufacturer or Morphine Sulfate supplier.
PharmaCompass also assists you with knowing the Morphine Sulfate API Price utilized in the formulation of products. Morphine Sulfate API Price is not always fixed or binding as the Morphine Sulfate Price is obtained through a variety of data sources. The Morphine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Duramorph manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Duramorph, including repackagers and relabelers. The FDA regulates Duramorph manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Duramorph API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Duramorph manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Duramorph supplier is an individual or a company that provides Duramorph active pharmaceutical ingredient (API) or Duramorph finished formulations upon request. The Duramorph suppliers may include Duramorph API manufacturers, exporters, distributors and traders.
click here to find a list of Duramorph suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Duramorph DMF (Drug Master File) is a document detailing the whole manufacturing process of Duramorph active pharmaceutical ingredient (API) in detail. Different forms of Duramorph DMFs exist exist since differing nations have different regulations, such as Duramorph USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Duramorph DMF submitted to regulatory agencies in the US is known as a USDMF. Duramorph USDMF includes data on Duramorph's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Duramorph USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Duramorph suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Duramorph Drug Master File in Korea (Duramorph KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Duramorph. The MFDS reviews the Duramorph KDMF as part of the drug registration process and uses the information provided in the Duramorph KDMF to evaluate the safety and efficacy of the drug.
After submitting a Duramorph KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Duramorph API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Duramorph suppliers with KDMF on PharmaCompass.
A Duramorph CEP of the European Pharmacopoeia monograph is often referred to as a Duramorph Certificate of Suitability (COS). The purpose of a Duramorph CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Duramorph EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Duramorph to their clients by showing that a Duramorph CEP has been issued for it. The manufacturer submits a Duramorph CEP (COS) as part of the market authorization procedure, and it takes on the role of a Duramorph CEP holder for the record. Additionally, the data presented in the Duramorph CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Duramorph DMF.
A Duramorph CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Duramorph CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Duramorph suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Duramorph as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Duramorph API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Duramorph as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Duramorph and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Duramorph NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Duramorph suppliers with NDC on PharmaCompass.
Duramorph Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Duramorph GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Duramorph GMP manufacturer or Duramorph GMP API supplier for your needs.
A Duramorph CoA (Certificate of Analysis) is a formal document that attests to Duramorph's compliance with Duramorph specifications and serves as a tool for batch-level quality control.
Duramorph CoA mostly includes findings from lab analyses of a specific batch. For each Duramorph CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Duramorph may be tested according to a variety of international standards, such as European Pharmacopoeia (Duramorph EP), Duramorph JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Duramorph USP).